Abstract | BACKGROUND: AIMS:
Dopamine was studied for effect on agonist induced human platelet Ca mobilization, human platelet GP iib iiia receptor activation and acute coronary thrombosis in dogs. Calcium sensitive indo-1, fluorescent immunostaining and flow cytometry were used for platelet studies while coronary thrombosis was induced in anesthetized dogs via endothelial damage, arterial wall injury and critical stenosis. RESULTS:
Dopamine 10 and 10 M had no effect on the amplitude of the platelet Ca signal evoked by thrombin 0.1 U/mL. Likewise, dopamine 10 M had no effect on GP IIb IIIa activation evoked by ADP 10 M and by thrombin 0.1 U/mL. In dogs, intravenous dopamine 8 ug/Kg/min had no effect on repetitive cycles of acute coronary thrombus formation. In positive control studies, epinephrine increased platelet responsiveness and accelerated canine coronary thrombosis. CONCLUSION: Clinically relevant concentrations of dopamine did not amplify agonist induced human platelet Ca activation, GPiib iiia expression or experimental canine coronary thrombosis--providing a degree of reassurance concerning this versatile inotrope.
|
Authors | John Christopher Sill, Brian Bertha, Ines Berger, Victoria Southorn, John Folts |
Journal | Journal of cardiovascular pharmacology
(J Cardiovasc Pharmacol)
Vol. 53
Issue 3
Pg. 246-52
(Mar 2009)
ISSN: 1533-4023 [Electronic] United States |
PMID | 19247190
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Cardiotonic Agents
- Platelet Glycoprotein GPIIb-IIIa Complex
- Adenosine Diphosphate
- Thrombin
- Calcium
- Dopamine
|
Topics |
- Acute Disease
- Adenosine Diphosphate
(pharmacology)
- Animals
- Blood Platelets
(drug effects, metabolism)
- Calcium
(metabolism)
- Cardiotonic Agents
(administration & dosage, adverse effects)
- Cells, Cultured
- Coronary Thrombosis
(chemically induced)
- Disease Models, Animal
- Dogs
- Dopamine
(administration & dosage, adverse effects)
- Dose-Response Relationship, Drug
- Flow Cytometry
- Humans
- Platelet Glycoprotein GPIIb-IIIa Complex
(agonists)
- Thrombin
(pharmacology)
|